From the Desk of Steve Strazza and Alfonso Depablos
The largest insider buy on today’s list comes in a Form 4 filing by Dirk Kersten.
Kersten, who is general partner at Forbion Capital Fund, reported a purchase of roughly $26 million in Dyne Therapeutics Inc $DYN.